This inventor holds 2 USPTO granted patents. Top assignees: Kyungpook National University Industry-Academic Cooperation Foundation, Chungbuk National University Industry-Academic Cooperation Foundation. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 368 
1 out of 46 Years Active: 2013-2018
Title: Kyung-Sik Song: Innovator in Pharmaceutical Composition
Introduction
Kyung-Sik Song is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions for treating various vascular inflammatory diseases.
Latest Patents
Kyung-Sik Song holds 2 patents. His latest patents include a pharmaceutical composition containing a 2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivative. This composition is effective against vascular inflammation-related infectious diseases triggered by the activity of the HMGB1 protein. His research has demonstrated an anti-sepsis effect through a CLP-induced sepsis animal test, showing an increased survival rate. Additionally, he has developed a composition for preventing or treating cerebral infarction, cerebral edema, cerebral ischemia, or vascular dementia, aimed at improving memory impairments and protecting neuronal cells.
Career Highlights
Kyung-Sik Song has worked with esteemed institutions such as the Kyungpook National University Industry-Academic Cooperation Foundation and the Chungbuk National University Industry-Academic Cooperation Foundation. His work has been pivotal in advancing pharmaceutical research and applications.
Collaborations
He has collaborated with notable colleagues, including Taeho Lee and Jong-Sup Bae, contributing to the innovative research in his field.
Conclusion
Kyung-Sik Song's contributions to pharmaceutical compositions highlight his role as an innovator in addressing critical health issues. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile